Efficacy of Antiviral Therapy After Radical Resection for Hepatitis B Virus-Related Hepatocellular Carcinoma
- Status
- UNKNOWN
- Phase
- PHASE4
Clinical Trials Related to Hepatocellular Carcinoma
Related studies linked through entity extraction aliases.
Tumor Growth Factors in Hepatocellular Carcinoma
- Status
- COMPLETED
- Phase
- N/A
SBRT + TACE for Primary Hepatocellular Carcinoma
- Status
- WITHDRAWN
- Phase
- NA
Study of Anti-tumour Effects and Safety of Prolarix™ in Hepatocellular Carcinoma
- Status
- TERMINATED
- Phase
- PHASE2
Low-Dose Thalidomide as Adjuvant Therapy After Radiofrequency Ablation for Hepatocellular Carcinoma
- Status
- UNKNOWN
- Phase
- PHASE2/PHASE3
Effect of I/R Injuries by Pringle Manoeuvre on the Prognosis of HCC Patients After Curative Hepatectomy
- Status
- COMPLETED
- Phase
- NA
The Risk of Exacerbation of Chronic Hepatitis B After Percutaneous Radiofrequency Ablation of Hepatocellular Carcinoma
- Status
- UNKNOWN
- Phase
- N/A
A Study of Mapatumumab in Combination With Sorafenib in Subjects With Advanced Hepatocellular Carcinoma
- Status
- COMPLETED
- Phase
- PHASE1
Study of SIR-Spheres Plus Sorafenib as 1st Line Treatment for Non-resectable Primary Hepatocellular Carcinoma (HCC)
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Evaluation of Quality of Life and Survival With MS-20 in Patient With Advanced Hepatocellular Carcinoma (FDA IND 74572)
- Status
- UNKNOWN
- Phase
- PHASE2
Efficacy and Safety of Immuncell-LC Group and Non-treatment Group in Hepatocelluar Carcinoma Patients
- Status
- COMPLETED
- Phase
- PHASE3
Study of TAC-101 as Second Line Treatment in Patients With Advanced Hepatocellular Carcinoma Who Received Sorafenib as First Line Therapy
- Status
- TERMINATED
- Phase
- PHASE2
TheraSphere HUD For Treatment of Unresectable Hepatocellular Carcinoma (HCC)
- Status
- COMPLETED
- Phase
- N/A
Evaluation the Growth Factors(IGF-1,IGFBP-3and HGH)in Patients With Chronic Liver Disease
- Status
- COMPLETED
- Phase
- N/A
Immunization With AFP + GM CSF Plasmid Prime and AFP Adenoviral Vector Boost in Patients With Hepatocellular Carcinoma
- Status
- TERMINATED
- Phase
- PHASE1
Hepatectomy With or Without Transcatheter Arterial Chemoembolization for Stage IIIA Hepatocellular Carcinoma
- Status
- COMPLETED
- Phase
- PHASE3
Transarterial Chemoembolization for Unresectable Hepatocellular Carcinoma With Portal Vein Tumor Thrombosis
- Status
- COMPLETED
- Phase
- PHASE4
Phase ⅡStudy of Tyroserleutide for Injection in Hepatocellular Carcinoma(HCC) Patients
- Status
- UNKNOWN
- Phase
- N/A
Risk Factors for the Leakage of Anticancer Drugs to Systemic Circulation by Transcatheter Arterial Chemoembolization
- Status
- COMPLETED
- Phase
- N/A
Genetic Polymorphisms of TNF-α Promoter and HBV Genotype on Outcome of HBV-Related Chronic Liver Disease
- Status
- UNKNOWN
- Phase
- NA